Chronic Idiopathic Constipation (CIC) Market Analysis, Leading Companies, Emerging Drugs and Epidemiology Forecast

September 10 20:05 2020
Chronic Idiopathic Constipation (CIC) Market Analysis, Leading Companies, Emerging Drugs and Epidemiology Forecast

DelveInsight Business Research LLP
DelveInsight’s “Chronic Idiopathic Constipation (CIC) Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the Chronic Idiopathic Constipation (CIC), historical and forecasted epidemiology as well as the Chronic Idiopathic Constipation (CIC) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Chronic idiopathic constipation (CIC) is a health condition in which a person experiences chronic symptoms of constipation, yet no visible cause can be identified through standard diagnostic testing. The term idiopathic is used because it means there is no known cause. CIC is also referred to as functional constipation or chronic constipation, and is classified as one of the functional gastrointestinal disorders (FGDs), meaning that although testing does not show any visible physical abnormality, there is a problem in the way that the digestive system, or in this case, the large intestine, is functioning.

The primary symptoms of Chronic idiopathic constipation CIC include: Infrequent bowel movements, straining, hard or lumpy stools, feeling of incomplete evacuation, feeling that something is blocking the stool from coming out, prolonged time to pass stool, or need for manual maneuvers to pass stool. CIC is defined as the presence of these symptoms for at least 3 months.

Various factors are involved in the pathogenesis of the disease, including type of diet, genetic predisposition, colonic motility, absorption, social economic status, daily behaviors, and biological and pharmaceutical factors. It is estimated that approximately 14% of the population experiences chronic constipation. People who are at higher risk include women, older individuals of all ages and genders, and those who have a lower socioeconomic status.

 

Get FREE sample copy at: 

https://www.delveinsight.com/sample-request/chronic-idiopathic-constipation-market

 

chronic-idiopathic-constipation-cic-market-size-share-trends-growth-analysis

The Chronic Idiopathic Constipation (CIC) market report also covers emerging drugs, current treatment practices, Chronic Idiopathic Constipation (CIC) market share of the individual therapies, current and forecasted Chronic Idiopathic Constipation (CIC) Market Size from 2017 to 2030 segmented by seven major markets. 

The report provides a detailed current Chronic Idiopathic Constipation (CIC) treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market. 

 

Chronic Idiopathic Constipation (CIC) Market Key Facts

Severe constipation is more common in elderly women, with rates of constipation two to three times higher than that of their male counterparts. [Ernest P Bouras et. al., 2015]

As per a study by Paul Enck, titled, “Prevalence of constipation in the German population – a representative survey (GECCO)”, the prevalence of constipation has been reported to be 5% in Germany. This is substantially lower than in other European countries and worldwide.

 

Key Benefits of Chronic Idiopathic Constipation (CIC) Market Report

  • Chronic Idiopathic Constipation (CIC) market report provides an in-depth analysis of Chronic Idiopathic Constipation (CIC) Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.

  • The Chronic Idiopathic Constipation (CIC) market report will help in developing business strategies by understanding the Chronic Idiopathic Constipation (CIC) Market trends & developments, key players and future market competition that will shape and drive the Chronic Idiopathic Constipation (CIC) market in the upcoming years.

  • The Chronic Idiopathic Constipation (CIC) market report covers Chronic Idiopathic Constipation (CIC) current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.

  • The report provides a detailed assessment of the Chronic Idiopathic Constipation (CIC) market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population,  comparative analysis of pipeline products with detailed clinical profiles, and other factors. 

 

Chronic Idiopathic Constipation (CIC) Market

As it is not possible to determine the cause of Chronic Idiopathic Constipation (CIC), the treatment options tend to be limited. Dietary changes, like increasing dietary fiber and water intake are usually helpful, as is doing regular physical exercise. However, diet, fluid intake and exercise are not uniformly effective, and some people with CIC may be recommended to use various pharmacological therapies.

The Chronic Idiopathic Constipation (CIC) market outlook section of the report helps to build the detailed comprehension of the historic, current and forecasted Chronic Idiopathic Constipation (CIC) market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology. 

The report gives a thorough detail of Chronic Idiopathic Constipation (CIC) market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders. 

 

Chronic Idiopathic Constipation (CIC) Epidemiology

The Chronic Idiopathic Constipation (CIC) epidemiology section covers insights about historical and current Chronic Idiopathic Constipation (CIC) patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.

It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

 

Chronic Idiopathic Constipation (CIC) Drugs Uptake and Key Market Players

The Chronic Idiopathic Constipation (CIC) Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Chronic Idiopathic Constipation (CIC) market or expected to get launched in the market during the study period. The analysis covers Chronic Idiopathic Constipation (CIC) market uptake by drugs; patient uptake by therapies; and sales of each drug.    

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The dynamics of Chronic Idiopathic Constipation market is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, rising awareness of the disease, incremental healthcare spending across the world and expected launch of emerging therapies during the forecast period of 2018-2028.

Some of the key players in the Chronic Idiopathic Constipation market includes:
Renexxion LLC
Kissei Pharmaceutical Co., Ltd.
Dainippon Sumitomo Pharma
Synergy Pharmaceuticals
Takeda
And many others.

 

Drugs Covered
KWA-0711
DSP 6952
Naronapride
And many others.

 

Table of Content

1. Key Insights

2. Executive Summary 

3. Chronic Idiopathic Constipation (CIC) Competitive Intelligence Analysis

4. Chronic Idiopathic Constipation (CIC) Market Overview at a Glance

5. Chronic Idiopathic Constipation (CIC) Disease Background and Overview

6. Chronic Idiopathic Constipation (CIC) Patient Journey

7. Chronic Idiopathic Constipation (CIC) Epidemiology and Patient Population

8. Chronic Idiopathic Constipation (CIC) Treatment Algorithm, Current Treatment, and Medical Practices

9. Chronic Idiopathic Constipation (CIC) Unmet Needs

10. Key Endpoints of Chronic Idiopathic Constipation (CIC) Treatment

11. Chronic Idiopathic Constipation (CIC) Marketed Products

12. Chronic Idiopathic Constipation (CIC) Emerging Therapies

13. Chronic Idiopathic Constipation (CIC) Seven Major Market Analysis

14. Attribute Analysis

15. Chronic Idiopathic Constipation (CIC) Market Outlook (7 major markets)

16. Chronic Idiopathic Constipation (CIC) Access and Reimbursement Overview

17. KOL Views on the Chronic Idiopathic Constipation (CIC) Market.

18. Chronic Idiopathic Constipation (CIC) Market Drivers

19. Chronic Idiopathic Constipation (CIC) Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

 

Related Reports

Chronic Idiopathic Constipation (CIC) Epidemiology Forecast to 2030

DelveInsight’s Chronic Idiopathic Constipation (CIC) Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Chronic Idiopathic Constipation (CIC) in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

 

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/